Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis.
about
A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory DiseasesBudesonide Multi-matrix for the Treatment of Patients with Ulcerative ColitisCurrent approaches to the management of new-onset ulcerative colitis.Don't Forget the Doctor: Gastroenterologists' Preferences on the Development of mHealth Tools for Inflammatory Bowel DiseaseImpact of Treatment-Related Beliefs on Medication Adherence in Immune-Mediated Inflammatory Diseases: Results of the Global ALIGN StudyAdherence in ulcerative colitis: an overview.Transition of the patient with IBD from pediatric to adult care-an assessment of current evidence.Patterns and Predictors of Long-term Nonuse of Medical Therapy Among Persons with Inflammatory Bowel Disease.Treatment Nonadherence in Inflammatory Bowel Disease: Identification, Scope, and Management Strategies.Opportunities for Improvement in the Care of Patients Hospitalized for Inflammatory Bowel Disease-Related Colitis.The problem of adherence to therapy in ulcerative colitis and the potential utility of multi-matrix system (MMX) technology.Economic impact of medication non-adherence by disease groups: a systematic review.Urinalysis of MMX-mesalazine as a tool to monitor 5-ASA adherence in daily IBD practice.Changes in health-related quality of life and work-related outcomes for patients with mild-to-moderate ulcerative colitis receiving short-term and long-term treatment with multimatrix mesalamine: a prospective, open-label study
P2860
Q26778585-B397D20D-BA06-47F9-AEE4-1D5FA200E368Q26779042-38A66509-E4A7-4DDE-82F0-739ECC4DF905Q33633288-102CD2AD-3CD8-4F8D-838F-81E8197A3B0CQ35056003-2520A7C7-E3D6-479D-BD2B-85002AD40BB4Q37562617-E59D9575-041A-4549-8141-24AF17099199Q37669367-1A001DFD-C2D6-4334-AE4C-5F48DC80CE70Q38213338-324717EB-BB49-4B59-BBD0-B42A25F657B2Q38414777-39EF3992-6DFD-4352-A0F1-7359D1E49299Q38583997-71C80A25-D517-4D23-9ABD-92D9E1B3CEEEQ38727510-9CFC592B-4D34-41BE-B761-693A96D6F445Q38996677-9B9EABA9-9B7B-439F-9360-517C064EA9A6Q47555825-FF27FA28-B5B7-4982-9CF9-134A6A643F3DQ48122081-E136AFC9-71F0-4924-ABCB-63ECD399617FQ57193103-46FB4F56-E872-41BD-8C7C-82718842FECB
P2860
Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Association between oral 5-ASA ...... ith active ulcerative colitis.
@ast
Association between oral 5-ASA ...... ith active ulcerative colitis.
@en
Association between oral 5-ASA ...... ith active ulcerative colitis.
@nl
type
label
Association between oral 5-ASA ...... ith active ulcerative colitis.
@ast
Association between oral 5-ASA ...... ith active ulcerative colitis.
@en
Association between oral 5-ASA ...... ith active ulcerative colitis.
@nl
prefLabel
Association between oral 5-ASA ...... ith active ulcerative colitis.
@ast
Association between oral 5-ASA ...... ith active ulcerative colitis.
@en
Association between oral 5-ASA ...... ith active ulcerative colitis.
@nl
P2093
P2860
P356
P1433
P1476
Association between oral 5-ASA ...... ith active ulcerative colitis.
@en
P2093
Debanjali Mitra
Keith L Davis
Linnette Yen
Paul Hodgkins
Russell D Cohen
P2860
P2888
P356
10.1186/1471-230X-12-132
P577
2012-09-24T00:00:00Z
P6179
1001097875